Bildkälla: Stockfoto

Active Biotech: Laquinimod Enters Eyes - Redeye

Redeye comments on an early readout from the intraocular biodistribution study of laquinimod that is ongoing in the US.

Redeye comments on an early readout from the intraocular biodistribution study of laquinimod that is ongoing in the US.
Börsvärldens nyhetsbrev
ANNONSER